Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

UCB SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Feb 2015 Reuters Investment Profile 12 $20.00

ValuEngine Industry Report for Medical-drugs(UCBJF)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

23 Feb 2015 ValuEngine, Inc. 10 $49.00

UCB S.A.

UCB S.A. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the compan...

16 Feb 2015 MarketLine (a Datamonitor Company) 57 $175.00

Is UCB SA a Good Long-Term Investment?

05 Feb 2015 Sadif Analytics Prime 11 $25.00

UCB S.A. (UCB) - Financial and Strategic SWOT Analysis Review

UCB S.A. (UCB) - Financial and Strategic SWOT Analysis Review Summary UCB S.A. (UCB) is a leading global biopharmaceutical co...

07 Jan 2015 GlobalData 56 $125.00

UCB SA: Downgraded to Below Average

05 Dec 2014 Sadif Analytics Prime 3 $10.00

UCB S.A. (UCB) - Financial and Strategic SWOT Analysis Review

UCB S.A. (UCB) - Financial and Strategic SWOT Analysis Review Summary UCB S.A. (UCB) is a leading global biopharmaceutical co...

02 Dec 2014 GlobalData 60 $125.00

Is UCB SA a Good Long-Term Investment?

13 Nov 2014 Sadif Analytics Prime 11 $25.00

UCB.BR - Event Transcript of UCB SA conference call, Nov. 07, 2014 / 8:30AM ET

Edited Event Transcript of UCB.BR conference call, Nov. 07, 2014 / 8:30AM ET Boston, Nov 10, 2014 (Thomson StreetEvents...

07 Nov 2014 Thomson Reuters StreetEvents 14 $75.00

UCB S.A. (UCB) - Financial and Strategic SWOT Analysis Review

UCB S.A. (UCB) - Financial and Strategic SWOT Analysis Review Summary UCB S.A. (UCB) is a leading global biopharmaceutical co...

15 Oct 2014 GlobalData 60 $125.00